Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureLaura Varela, Patricia San Martín, Fabiana Caballero, Marcelo Guolo, Ana María Buzaleh, Victoria Parera, Viviana Melito
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals
10.1016/j.tjog.2016.03.004 · 2016
Testosterone therapy for transgender men
10.1016/s2213-8587(16)00036-x · 2017
Management of adverse effects in testosterone replacement therapy
10.1590/s1677-5538.ibju.2025.9904 · 2025
Recommendations for the diagnosis and treatment of the acute porphyrias
10.7326/0003-4819-142-6-200503150-00010 · 2005
Porphyrias
10.1016/s0140-6736(09)61925-5 · 2010
The porphyrias: advances in diagnosis and treatment
10.1182/blood-2012-05-423186 · 2012
Metabolismo del hemo: las dos caras de los efectos de la acumulación de precursores y porfirinas
2016
Heme biosynthesis and the porphyrias
10.1016/j.ymgme.2019.04.008 · 2019
Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of argentine patients
10.1002/mgg3.1059 · 2021
Acute intermittent porphyria in Argentina: an update
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1155/2015/946387 · 2015
Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease
10.1002/humu.23067 · 2016
Acute hepatic porphyrias
10.1097/j.pbj.0000000000000308 · 2025
Porphyrias: pathophysiology and clinical management recommendations for hepatologists
10.1097/hc9.0000000000000822 · 2025
Unresolved referenced work
2026
Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps
10.1074/jbc.m501854200 · 2005
Porphyria
2003
Chapter 56 - Porphyria and its neurologic manifestations
10.1016/b978-0-7020-4087-0.00056-5 · 2014
Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline
10.1210/jc.2017-01658 · 2017
Hormonal gender reassignment treatment for gender dysphoria
2020
Transdermal testosterone delivery: testosterone patch and gel
10.1007/s00345-003-0368-6 · 2003
Drug-associated porphyria: a pharmacovigilance study
10.1186/s13023-024-03294-8 · 2024
Studies in porphyria: VIII. Relationship of the 5α-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria
10.1016/0002-9343(79)91176-8 · 1979
Developmental biology of heme oxygenase
10.1016/s0095-5108(18)30568-2 · 1990
Role of heme oxygenase as a modulator of heme-mediated pathways
2019
Guidelines for the management of acute porphyria: recommendations from the international Porphyria network
10.1016/s2352-3026(26)00044-x · 2026
Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria
10.3109/00016340903390729 · 2010
Acute intermittent porphyria treated by testosterone implant
10.1136/pgmj.68.800.479 · 1992
Treatment with assisted reproduction technologies in women with acute hepatic porphyria
10.1111/aogs.14200 · 2021
Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy
10.1016/j.jdcr.2020.04.036 · 2020
Acute variegate Porphyria in a professional bodybuilder after starting a high-protein diet and treatment with testosterone
10.2340/00015555-3769 · 2021
No additional external references are available.